BRIEF

on MEMSCAP (EPA:MEMS)

MEMSCAP half-year report: decline in turnover but profitability maintained

Stock price chart of MEMSCAP (EPA:MEMS) showing fluctuations.

In the first half of 2025, MEMSCAP recorded consolidated revenue of €6.1 million, down 16% compared to 2024. This decline was mainly due to a decrease in sales in the medical sector, where revenue fell by €1.0 million following the compliance upgrade of a major customer's systems. However, the avionics sector showed notable resilience with a slight decline of 3%.

Even with these results, the company was able to maintain a gross margin of 41.8%, higher than that of 2024. Net profit amounted to €0.4 million, despite a decrease compared to the previous year (€1.0 million). MEMSCAP thus presented an adjusted EBITDA of €0.7 million, indicating good cost management and solid profitability in an uncertain economic context.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MEMSCAP news